C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2009
12/17/2009	WO2009150129A1 Heterocyclic derivatives as hdac inhibitors
12/17/2009	WO2009150109A1 Imidazolidine derivatives
12/17/2009	WO2009149649A1 Aralkyl alcohol piperidine derivative and the use as medicament for treating depression thereof
12/17/2009	WO2009114950A8 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
12/17/2009	WO2009092590A3 2 -cyano phenyl sulfonamide derivatives useful as pesticides
12/17/2009	WO2009068284A3 Process for the stereoselective reduction of ketoimines catalysed by trichlorosilane
12/17/2009	US20090312370 Macrocyclic compounds useful as bace inhibitors
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009	US20090312344 Arylpiperazine derivatives as adrenergic receptor antagonists
12/17/2009	US20090312329 Cyclic hydroxylamine as psychoactive compounds
12/17/2009	US20090312307 Heterocyclo inhibitors of potassium channel function
12/17/2009	US20090312304 Organic compounds
12/17/2009	CA2726158A1 Compounds and compositions useful for the treatment of malaria
12/17/2009	CA2725654A1 Imidazolidine derivatives
12/16/2009	EP2133334A1 Heterocyclic derivatives as HDAC inhibitors
12/16/2009	EP2133078A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
12/16/2009	EP2132176A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
12/16/2009	EP2132175A2 Process for the preparation of loperamide
12/16/2009	EP2132174A1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
12/16/2009	EP1904057B1 Hydroquinone ansamycins in the treatment of gastrointestinal stromal tumors
12/16/2009	EP1888567B1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
12/16/2009	CN101602877A Method for preparing radiation and aging resistant polypropylene alloys
12/16/2009	CN101602872A Method for preparing radiation aging resistant polypropylenes
12/16/2009	CN101602710A New preparation method of key intermediate of clevidipine butyrate
12/16/2009	CN101602709A Method for preparing cilnidipine used as dihydropyridine calcium antagonist
12/16/2009	CN101602708A Aryl alkanol piperidine derivative and application thereof as antidepressive medicine
12/16/2009	CN100569751C Production of 1-benzyl-4-piridocarbinol
12/16/2009	CN100569738C Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
12/15/2009	US7632949 condensation of isophthalic acic dichloride (IPC) with sterically hindered amines of the type tetraalkylpiperidine; by using organic solvents or mixtures of organic solvents with water and by an optimized combination of temperature and pressure the yield is much higher than by using water alone
12/15/2009	US7632858 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly
12/15/2009	US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
12/15/2009	US7632849 Indazolamides with analgesic activity
12/15/2009	US7632847 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(3-[3-(4-hydroxybenzylamino)propionylamino]benzoylamino)ethyl)piperidin-4-yl ester
12/15/2009	CA2529611C Pyrimidine derivatives for the treatment of abnormal cell growth
12/15/2009	CA2374580C Oligomers and polymers of cyclic imino carboxylic acids
12/10/2009	WO2009148046A1 Method of producing optically active amino acid derivative
12/10/2009	WO2009147219A1 New compounds vii
12/10/2009	WO2009147149A1 Compounds comprising a cyclobutoxy group
12/10/2009	WO2009146648A1 Amide compounds, preparation methods and uses thereof
12/10/2009	WO2009146540A1 N-piperidinyl acetamide derivatives as calcium channel blockers
12/10/2009	WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/10/2009	WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009	US20090306392 Gsm intermediates
12/10/2009	US20090306391 Method for deprotecting aryl or alkyl sulfonamides of primary or secondary amines
12/10/2009	US20090306382 Cationic alkoxyamines
12/10/2009	US20090306150 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
12/10/2009	US20090306141 Novel Compounds
12/10/2009	US20090306138 chemokine receptor antagonists, such as 1-{3-[3-(4-fluorophenoxy)pyrrolidine-1-yl]propyl}-3-(3-methoxyphenyl)-urea, used as antiinflammatory agents
12/10/2009	US20090306136 Benzenesulfonamide Compounds and the Use Thereof
12/10/2009	US20090306135 Stable amorphous fexofenadine hydrochloride
12/10/2009	US20090306134 Muscarinic receptor antagonists
12/10/2009	US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009	US20090306115 Phenyl ethyne compounds
12/10/2009	US20090306077 Novel n- (2-aminophenyl) benzamide derivative having urea structure
12/10/2009	US20090306042 Novel Compounds 010
12/10/2009	US20090306016 Fatty acid amide hydrolase inhibitors
12/10/2009	CA2726646A1 New compounds vii
12/10/2009	CA2723626A1 Compounds comprising a cyclobutoxy group
12/10/2009	CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/09/2009	EP2130538A1 Use of a cholinesterase inhibitor for the delaying the onset of Alzheimer's disease
12/09/2009	EP2129659A1 Alpha-hydroxyketones
12/09/2009	EP2129652A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors
12/09/2009	EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
12/09/2009	CN101600693A Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/09/2009	CN101600692A Stable S-nitrosothiols, method of synthesis and use
12/09/2009	CN101600691A Piperidinyl derivatives as modulators of chemokine receptor activity
12/09/2009	CN101597247A N-sulfinyl amino acid amide compound and application thereof
12/09/2009	CN100567288C 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
12/09/2009	CN100567268C Process for synthesis of amine ethers from secondary amino oxides
12/09/2009	CN100567267C Arylamidine derivative, salt thereof, and antifungal containing these
12/09/2009	CN100567266C Cannabinoid receptor ligands
12/09/2009	CN100567242C Hsp90 family protein inhibitors
12/09/2009	CN100566714C Compositions of huperzia serrata alkaloids comprising huperzine A and huperzine B and preparation thereof
12/08/2009	US7629472 Preparing a beta-hydroxy-beta-heteroaryl ester by reacting a beta-halozinc ester Reformatsky reagent with an alpha-carbonylheteroaryl compound in the presence of a cinchona alkaloid; the heteroaryl is preferably an optionally substituted 2-pyridyl group or 4-imidazolyl group; stereospecific; drugs
12/08/2009	US7629471 Transcriptional factor, process for producing the same and use thereof
12/08/2009	US7629366 Aminoalcohol derivatives
12/08/2009	US7629363 Diaryl substituted pyridinones
12/08/2009	US7629336 Biphenyl compounds useful as muscarinic receptor antagonists
12/03/2009	WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009	WO2009143630A1 Creatine sugar amides and salts thereof
12/03/2009	WO2009110002A4 Novel efflux pump inhibitors
12/03/2009	US20090298893 Addition Salts of Tolperisone, Processes for Their Preparation and Use Thereof
12/03/2009	US20090298879 Impurities of Donepezil
12/03/2009	US20090298878 Oxime compounds and the use thereof
12/03/2009	US20090298877 Salts of creatine imino sugar amides
12/03/2009	US20090298872 Compounds and compositions as modulators of steroidal receptors and calcium channel activities
12/03/2009	US20090298840 Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
12/03/2009	US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity
12/03/2009	US20090298808 Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
12/03/2009	US20090297685 Preparations containing creatine and imino sugars
12/03/2009	CA2729812A1 Therapeutic agent for alzheimer's disease
12/02/2009	EP2128135A1 Method for synthesis of nitroxyl radical
12/02/2009	EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
12/02/2009	EP2125733A1 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds
12/02/2009	EP2125732A1 Symmetric azo compounds in flame retardant compositions
12/02/2009	EP2125731A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/02/2009	EP2125730A2 New process for remifentanil synthesis
12/02/2009	EP2125729A1 Processes for the preparation of piperidinyl-substituted urea compounds

1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 380